Differential diagnosis of genetic causes of left ventricular hypertrophy (LVH) is crucial for disease-specific therapy. We aim to describe the prevalence of Cardiac Amyloidosis (CA) among patients ≥40 years with an initial diagnosis of HCM referred for second opinion to national cardiomyopathy centres.
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy / Maurizi, Niccolò; Rella, Valeria; Fumagalli, Carlo; Salerno, Sabrina; Castelletti, Silvia; Dagradi, Federica; Torchio, Margherita; Marceca, Azzurra; Meda, Martino; Gasparini, Massimo; Boschi, Beatrice; Girolami, Francesca; Parati, Gianfranco; Olivotto, Iacopo; Crotti, Lia; Cecchi, Franco. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - ELETTRONICO. - (2020), pp. 0-0. [10.1016/j.ijcard.2019.07.051]
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy
Maurizi, Niccolò;Fumagalli, Carlo;Girolami, Francesca;Olivotto, Iacopo;Cecchi, Franco
2020
Abstract
Differential diagnosis of genetic causes of left ventricular hypertrophy (LVH) is crucial for disease-specific therapy. We aim to describe the prevalence of Cardiac Amyloidosis (CA) among patients ≥40 years with an initial diagnosis of HCM referred for second opinion to national cardiomyopathy centres.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2019 Maurizi amiloidosi tra le HCM IJC proofs.pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Tutti i diritti riservati
Dimensione
521.1 kB
Formato
Adobe PDF
|
521.1 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
